3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow berotralstat: new trials by email Literature Review of berotralstat trials Research Report on berotralstat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long Term Safety Study of BCX7353 in Hereditary Angioedema BCX7353 - Hereditary Angioedema, HAE | Phase 2 / Phase 3 | Completed | BioCryst Pharmaceuticals | 387 | 2018-02-16 | 2023-06-18 |
| Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema BCX7353, Placebo - Hereditary Angioedema (HAE) | Phase 2 | Completed | BioCryst Pharmaceuticals | 58 | 2017-07-31 | 2021-04-01 |
| Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema BCX7353, Placebo - Hereditary Angioedema (HAE) | Phase 2 | Completed | BioCryst Pharmaceuticals | 75 | 2016-08-01 | 2021-03-23 |
Austria (3) · Denmark (3) · Germany (3) · Hungary (3) · Italy (3) · North Macedonia (3) · Switzerland (3) · United Kingdom (3) · Australia (2) · France (2) · Israel (2) · Poland (2) · Spain (2) · Canada (1) · Hong Kong (1)
Henriette Farkas, MD (1) · Hilary Longhurst, MBBS, PhD (1)
PMID 36408587, PMID 30044938, PMID 34161665, PMID 35820771, PMID 36326435, PMID 38006972, PMID 38020288, PMID 40490218